Aucta Pharmaceuticals Announces Licensing of Vigabatrin for Oral Solution in China
Aucta Pharmaceuticals, Inc , a technology based company focusing on the development and commercialization of Branded Specialty Products, announced that the Company has entered...
Omeros and Lonza Enter Long-Term Manufacturing Agreement for Commercial Supply of Narsoplimab
Omeros Corporation and Lonza announced a long-term manufacturing agreement for commercial production of narsoplimab, Omeros’ lead human monoclonal antibody targeting mannan-binding lectin-associated serine protease-2...
Vesselon Acquires FDA-Approved Lipid Microsphere Drug Imagent For Therapeutic Platform
Vesselon (www.vesselon.com) an oncology therapeutics company, announced the acquisition of an FDA-approved drug Imagent. Vesselon will use Imagent to create novel therapeutic complexes in...
Neuropore Therapies and BenevolentAI Enter Strategic Collaboration to Discover Novel Therapeutics Through the Application of Artificial Intelligence
Neuropore Therapies, Inc. announce that it entered into a collaboration with BenevolentAI to evaluate molecular targets implicated in progressive degenerative diseases which were identified...
Amicus Announces Positive Interim Clinical Data for AAV Gene Therapy in Children with CLN6 Batten Disease
Amicus Therapeutics announced positive interim results from its CLN6 Batten disease gene therapy program licensed from the Abigail Wexner Research Institute (AWRI) at Nationwide...
New Advanced DualBeam Increases Productivity and Expands Ease-of-Use
Thermo Fisher Scientific unveiled its most advanced focused ion beam scanning electron microscope (FIB-SEM) for materials science researchers and engineers, the Thermo Scientific Helios...
Lonza Partners with Vineti Across its Cell and Gene Therapy Manufacturing Network to Optimize Vein to Vein Delivery Service
Lonza and Vineti announced their partnership in the cell and gene therapy field and across Lonza's 'vein-to-vein' delivery network. As a part of this...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...